Goldman Sachs Knock-Out AZN/ DE000GG74AQ0 /
2024-05-16 11:09:31 AM | Chg.-0.100 | Bid2:22:19 PM | Ask2:22:19 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.690EUR | -12.66% | 0.760 Bid Size: 20,000 |
0.770 Ask Size: 20,000 |
Astrazeneca PLC ORD ... | 115.5972 GBP | 2078-12-31 | Call |
GlobeNewswire
2:00 PM
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
1:00 PM
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 f...
GlobeNewswire
05-15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...